C16 Biosciences
PrivateLast Round
Grant
Jan 24, 2024
Total Funding Raised
$28.5M
Company Overview
C16 Biosciences operates in Energy & Sustainability and is based in New York City, New York. Its latest recorded funding round was a Grant round in January 2024.
C16 Biosciences is a biotechnology company that has developed a proprietary biomanufacturing platform to produce sustainable alternatives to palm oil and other fats.
Sector
Energy & Sustainability
Verticals
Biotechnology, Sustainable Materials, Fashion & Beauty, Circular Economy
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
C16 Biosciences Comparables
Compare C16 Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NoPalm Ingredients | 89% | |
| Xylome Corporation | 88% | |
| Clean Food Group | 87% |
For institutional investors. Book with your work email.
C16 Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 24, 2024 | ||||
| Accelerator | Oct 17, 2023 | ||||
| VC Round | Mar 22, 2023 | ||||
| Series A | Mar 2, 2020 | ||||
| Seed | Nov 21, 2018 |
For institutional investors. Book with your work email.
C16 Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elemental Impact | Accelerator, Grant |
| Gates Foundation | Grant |
| Breakthrough Energy Ventures | Series A |
| Waldencast | Series A |
| The Bill & Melinda Gates Foundation Trust | Grant |
| Sound Ventures | Series A, Seed |
| Y Combinator | Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 24, 2024
$4M grant round led by The Bill & Melinda Gates Foundation Trust
- Oct 17, 2023
$1M raised from Elemental Impact
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesSep 2, 2026
C16 Biosciences, Inc. launches its Palmless fermented cocoa butter equivalent, made through aerobic precision fermentation and used by multinational food manufacturers in product development, as reported on Sep 2nd '26.
For institutional investors. Book with your work email.
C16 Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about C16 Biosciences's valuation, stock price, and market status.
Is C16 Biosciences a public or private company?
C16 Biosciences is a private company.
What is the current stock price of C16 Biosciences?
C16 Biosciences is a private company, so its shares have no public market price. Caplight tracks C16 Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is C16 Biosciences worth (valuation)?
Valuation information for C16 Biosciences is not publicly available.
Can I buy C16 Biosciences stock?
C16 Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was C16 Biosciences's last funding round?
C16 Biosciences's most recent funding round was Grant on January 24, 2024.
Who are the main investors in C16 Biosciences?
Key investors in C16 Biosciences include Breakthrough Energy Ventures, The Bill & Melinda Gates Foundation Trust.
Will C16 Biosciences IPO soon?
No public IPO plans have been announced for C16 Biosciences.
How can I track C16 Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in C16 Biosciences's shares on secondary markets.